Cargando…

Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation

Somatic mutations of STK11 or KEAP1 are associated with poor clinical outcomes for advanced non-small-cell lung cancer (aNSCLC) patients receiving immune checkpoint inhibitors (ICIs), chemotherapy, or targeted therapy. Which treatment regimens work better for STK11 or KEAP1 mutated (SKmut) aNSCLC pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Wei, Gan, Lu, Wang, Xin, Gu, Kai, Qian, Fang-Fei, Hu, Min-Juan, Zhang, Ding, Chen, Shi-Qing, Lu, Jun, Cao, Shu-Hui, Li, Jing-Wen, Wang, Yue, Zhang, Bo, Wang, Shu-Yuan, Li, Chang-Hui, Yang, Ping, Xu, Mi–Die, Zhang, Xue-Yan, Zhong, Hua, Han, Bao-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833760/ https://www.ncbi.nlm.nih.gov/pubmed/33537171 http://dx.doi.org/10.1080/2162402X.2020.1865670

Ejemplares similares

The negative relationship between patients with NSCLC harbored STK11/KEAP1 copy number variation and immune microenvironment infiltration
por: Zhang, Chenyue
Publicado: (2021)

A non-linear association between blood tumor mutation burden and prognosis in NSCLC patients receiving atezolizumab
por: Nie, Wei, et al.
Publicado: (2020)

XPO1-mutant NSCLC without STK11/KEAP1 mutations may predict better survival to immunotherapy
por: Li, Xuanzong, et al.
Publicado: (2021)

STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
por: Papillon-Cavanagh, Simon, et al.
Publicado: (2020)

Characterization of the STK11 splicing variant as a normal splicing isomer in a patient with Peutz–Jeghers syndrome harboring genomic deletion of the STK11 gene
por: Masuda, Kenta, et al.
Publicado: (2016)

Correction: STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
Publicado: (2020)

Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer
por: Wohlhieter, Corrin A., et al.
Publicado: (2020)

Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting
por: Julian, Cristina, et al.
Publicado: (2023)

Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial
por: West, Howard Jack, et al.
Publicado: (2022)

Exceptional durable response to everolimus in a patient with biphenotypic breast cancer harboring an STK11 variant
por: Parachoniak, Christine A., et al.
Publicado: (2017)

Concurrent Mutations in STK11 and KEAP1 Cause Treatment Resistance in KRAS Wild-type Non-small-cell Lung Cancer
por: Sumii, Masahiko, et al.
Publicado: (2023)

Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation
por: An, Josiah, et al.
Publicado: (2021)

Role of STK11 in ALK-positive non-small cell lung cancer
por: Zhou, Wen, et al.
Publicado: (2022)

High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia
por: Yu, Xibao, et al.
Publicado: (2023)

miR-424 Promotes Bovine Adipogenesis Through an Unconventional Post-Transcriptional Regulation of STK11
por: Wang, Li, et al.
Publicado: (2020)

Peutz-Jeghers syndrome without STK11 mutation may correlate with less severe clinical manifestations in Chinese patients
por: Jiang, Li-Xin, et al.
Publicado: (2023)

Clinical characteristics and STK11 gene mutations in Chinese children with Peutz-Jeghers syndrome
por: Huang, Zhiheng, et al.
Publicado: (2015)

Peutz-Jeghers syndrome with germline mutation of STK11
por: Chae, Hyun-Dong, et al.
Publicado: (2014)

Knockout of STK10 promotes the migration and invasion of cervical cancer cells
por: Zhang, Lu, et al.
Publicado: (2020)

STK1p as a prognostic biomarker for overall survival in non-small-cell lung carcinoma, based on real-world data
por: Wang, Zhenxin, et al.
Publicado: (2020)

Immunotherapy Mechanism of Esophageal Squamous Cell Carcinoma with the Effect of STK11/AMPK Signaling Pathway
por: Xia, Yang, et al.
Publicado: (2022)

Stk10 Deficiency in Mice Promotes Tumor Growth by Dysregulating the Tumor Microenvironment
por: Ma, Jin-Xia, et al.
Publicado: (2022)

The altered activity of P53 signaling pathway by STK11 gene mutations and its cancer phenotype in Peutz-Jeghers syndrome
por: Jiang, Yu-Liang, et al.
Publicado: (2018)

Mutations in STK11 gene in Czech Peutz-Jeghers patients
por: Vasovčák, Peter, et al.
Publicado: (2009)

Mutational Analysis of STK11 h Gene in Ovarian Carcinomas
por: Nishioka, Yoshihiro, et al.
Publicado: (1999)

Serine/Threonine Protein Kinase STK16
por: Wang, Junjun, et al.
Publicado: (2019)

Construction of an STK11 Mutation and Immune-Related Prognostic Prediction Model in Lung Adenocarcinoma
por: Tang, Bo, et al.
Publicado: (2023)

A novel pathogenic splice site variation in STK11 gene results in Peutz–Jeghers syndrome
por: Zhao, Na, et al.
Publicado: (2021)

Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non–Small Cell Lung Cancer
por: Ramagopalan, Sreeram, et al.
Publicado: (2021)

Tumor loss-of-function mutations in STK11/LKB1 induce cachexia
por: Iyengar, Puneeth, et al.
Publicado: (2023)

A novel mutation in the STK11 gene causes heritable Peutz-Jeghers syndrome - a case report
por: Chen, Jing-Hui, et al.
Publicado: (2017)

Deletion of Stk40 impairs definitive erythropoiesis in the mouse fetal liver
por: Wang, Lina, et al.
Publicado: (2017)

Complete STK11 Deletion and Atypical Symptoms in Peutz-Jeghers Syndrome
por: Jang, Myeong Sun, et al.
Publicado: (2017)

STK11 is required for the normal program of ciliated cell differentiation in airways
por: Chu, Qiqi, et al.
Publicado: (2019)

Association between STK11 Gene Polymorphisms and Coronary Artery Disease in Type 2 Diabetes in Han Population in China
por: Ma, Xiaowei, et al.
Publicado: (2017)

Lung adenocarcinoma patients with KEAP1 mutation harboring low immune cell infiltration and low activity of immune environment
por: Cheng, Wanwan, et al.
Publicado: (2021)

Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience
por: Ogawa, Keita, et al.
Publicado: (2022)

Correlation between STK33 and the pathology and prognosis of lung cancer
por: Lu, Yi, et al.
Publicado: (2017)

Relevance of STK11 Mutations Regarding Immune Cell Infiltration, Drug Sensitivity, and Cellular Processes in Lung Adenocarcinoma
por: Li, Zhenqing, et al.
Publicado: (2020)

A novel mutation in STK11 gene is associated with Peutz-Jeghers Syndrome in Chinese patients
por: Wang, Zhiqing, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8h9gmfgkvd0v8tlc9d5ka0mfd1